Insights

Strategic Partnerships Biocartis has established partnerships with key players in the industry such as Eli Lilly and APIS Assay Technologies, indicating potential collaboration opportunities for sales teams to explore joint initiatives and leverage each other's expertise.

Growing Test Menu With an expanding test menu focusing on oncology and infectious diseases, Biocartis presents sales opportunities for introducing new diagnostic solutions to healthcare providers, tapping into the high demand in these rapidly growing market segments.

Expert Talent Acquisition Recent hires of top executives like Dr. W. Michael Korn, Judith Vacchino, and George Cardoza demonstrate Biocartis' commitment to expertise, opening avenues for sales teams to engage with a knowledgeable leadership team to drive business expansion and strategic initiatives.

International Expansion As a global company headquartered in Belgium, Biocartis offers sales prospects for international expansion by exploring new markets, establishing distribution channels, and adapting its molecular testing solutions to meet the personalized medicine needs of diverse patient populations worldwide.

Post-Commercial Collaboration The collaboration with Lilly for biomarker testing for NSCLC patients using the Idylla™ platform signals post-commercial sales opportunities to provide tailored solutions for specific therapeutic areas, potentially leading to increased adoption and revenue growth through targeted offerings.

Biocartis Tech Stack

Biocartis uses 8 technology products and services including Cloudflare CDN, Drupal, Font Awesome, and more. Explore Biocartis's tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • Drupal
    Content Management System
  • Font Awesome
    Font Scripts
  • OWL Carousel
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Swiper
    Javascript Libraries
  • Apache HTTP Server
    Web Servers
  • Facebook
    Widgets

Media & News

Biocartis's Email Address Formats

Biocartis uses at least 1 format(s):
Biocartis Email FormatsExamplePercentage
FLast@biocartis.comJDoe@biocartis.com
65%
First.Last@biocartis.comJohn.Doe@biocartis.com
21%
First@biocartis.comJohn@biocartis.com
11%
FMLast@biocartis.comJMDoe@biocartis.com
3%

Frequently Asked Questions

Where is Biocartis's headquarters located?

Minus sign iconPlus sign icon
Biocartis's main headquarters is located at Generaal de Wittelaan 11B Mechelen, 2800 BE. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is Biocartis's phone number?

Minus sign iconPlus sign icon
You can contact Biocartis's main corporate office by phone at +32-15-63-26-00. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Biocartis's official website and social media links?

Minus sign iconPlus sign icon
Biocartis's official website is biocartis.com and has social profiles on LinkedIn.

How much revenue does Biocartis generate?

Minus sign iconPlus sign icon
As of July 2024, Biocartis's annual revenue reached $750M.

What is Biocartis's NAICS code?

Minus sign iconPlus sign icon
Biocartis's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Biocartis have currently?

Minus sign iconPlus sign icon
As of July 2024, Biocartis has approximately 501 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: R. M.Chief Business Officer: G. W.Chief Financial Officer And Head Of Service Delivery: G. C.. Explore Biocartis's employee directory with LeadIQ.

What industry does Biocartis belong to?

Minus sign iconPlus sign icon
Biocartis operates in the Medical Equipment Manufacturing industry.

What technology does Biocartis use?

Minus sign iconPlus sign icon
Biocartis's tech stack includes Cloudflare CDNDrupalFont AwesomeOWL CarouseljQuerySwiperApache HTTP ServerFacebook.

What is Biocartis's email format?

Minus sign iconPlus sign icon
Biocartis's email format typically follows the pattern of . Find more Biocartis email formats with LeadIQ.

How much funding has Biocartis raised to date?

Minus sign iconPlus sign icon
As of July 2024, Biocartis has raised $1.4M in funding. The last funding round occurred on Sep 30, 2020 for $1.4M.

When was Biocartis founded?

Minus sign iconPlus sign icon
Biocartis was founded in 2007.
Biocartis

Biocartis

Medical Equipment ManufacturingMechelen, Belgium501-1000 Employees

Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. Our proprietary MDx Idylla™ platform is a fully automated, real time system which offers accurate, highly-reliable molecular information from any biological sample in virtually any setting. Idylla™ addresses the growing demand for personalized medicine by allowing fast and effective treatment selection and treatment progress monitoring.
 
Biocartis is developing and marketing a rapidly expanding test menu addressing key unmet clinical needs with a focus in oncology, and expanding its test menu in infectious diseases with partners. These areas represent respectively the fastest and largest growing segments of the US$6.5 billion molecular diagnostics market. 

Biocartis’ vision is to enable personalized medicine for patients around the world through universal access to molecular testing. Our mission is to make molecular testing actionable, convenient, fast and suitable for any lab.
Biocartis employs over 500 people and is headquartered in Mechelen, Belgium. Further information? Visit www.biocartis.com

Section iconCompany Overview

Headquarters
Generaal de Wittelaan 11B Mechelen, 2800 BE
Phone number
+32-15-63-26-00
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2007
Employees
501-1000

Section iconFunding & Financials

  • $1.4M

    Biocartis has raised a total of $1.4M of funding over 9 rounds. Their latest funding round was raised on Sep 30, 2020 in the amount of $1.4M.

  • $100M$1B

    Biocartis's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $1.4M

    Biocartis has raised a total of $1.4M of funding over 9 rounds. Their latest funding round was raised on Sep 30, 2020 in the amount of $1.4M.

  • $100M$1B

    Biocartis's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.